Literature DB >> 23329591

A systematic and critical review of the evolving methods and applications of value of information in academia and practice.

Lotte Steuten1, Gijs van de Wetering, Karin Groothuis-Oudshoorn, Valesca Retèl.   

Abstract

OBJECTIVE: This article provides a systematic and critical review of the evolving methods and applications of value of information (VOI) in academia and practice and discusses where future research needs to be directed.
METHODS: Published VOI studies were identified by conducting a computerized search on Scopus and ISI Web of Science from 1980 until December 2011 using pre-specified search terms. Only full-text papers that outlined and discussed VOI methods for medical decision making, and studies that applied VOI and explicitly discussed the results with a view to informing healthcare decision makers, were included. The included papers were divided into methodological and applied papers, based on the aim of the study.
RESULTS: A total of 118 papers were included of which 50 % (n = 59) are methodological. A rapidly accumulating literature base on VOI from 1999 onwards for methodological papers and from 2005 onwards for applied papers is observed. Expected value of sample information (EVSI) is the preferred method of VOI to inform decision making regarding specific future studies, but real-life applications of EVSI remain scarce. Methodological challenges to VOI are numerous and include the high computational demands, dealing with non-linear models and interdependency between parameters, estimations of effective time horizons and patient populations, and structural uncertainties.
CONCLUSION: VOI analysis receives increasing attention in both the methodological and the applied literature bases, but challenges to applying VOI in real-life decision making remain. For many technical and methodological challenges to VOI analytic solutions have been proposed in the literature, including leaner methods for VOI. Further research should also focus on the needs of decision makers regarding VOI.

Entities:  

Mesh:

Year:  2013        PMID: 23329591     DOI: 10.1007/s40273-012-0008-3

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  129 in total

1.  Incorporating option values into the economic evaluation of health care technologies.

Authors:  S Palmer; P C Smith
Journal:  J Health Econ       Date:  2000-09       Impact factor: 3.883

2.  Efficient computation of partial expected value of sample information using Bayesian approximation.

Authors:  Alan Brennan; Samer A Kharroubi
Journal:  J Health Econ       Date:  2006-08-30       Impact factor: 3.883

3.  Exploring the research decision space: the expected value of information for sequential research designs.

Authors:  Susan Griffin; Nicky J Welton; Karl Claxton
Journal:  Med Decis Making       Date:  2009-12-29       Impact factor: 2.583

4.  Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis.

Authors:  E Wilson; K Gurusamy; C Gluud; B R Davidson
Journal:  Br J Surg       Date:  2010-02       Impact factor: 6.939

5.  Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitors.

Authors:  Nicholas Latimer; Joanne Lord; Robert L Grant; Rachel O'Mahony; John Dickson; Philip G Conaghan
Journal:  Pharmacoeconomics       Date:  2011-03       Impact factor: 4.981

6.  Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.

Authors:  Robert R Quinn; David M J Naimark; Matthew J Oliver; Ahmed M Bayoumi
Journal:  Am J Kidney Dis       Date:  2007-09       Impact factor: 8.860

7.  Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.

Authors:  Ties Hoomans; Elisabeth A L Fenwick; Steve Palmer; Karl Claxton
Journal:  Value Health       Date:  2008-07-24       Impact factor: 5.725

8.  Research decisions in the face of heterogeneity: what can a new study tell us?

Authors:  Nicky Welton; A E Ades
Journal:  Health Econ       Date:  2011-11-03       Impact factor: 3.046

9.  Comprehensive decision-analytic model and Bayesian value-of-information analysis: pentoxifylline in the treatment of chronic venous leg ulcers.

Authors:  Cynthia P Iglesias; Karl Claxton
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

10.  Analysis of cost effectiveness of screening Danish men aged 65 for abdominal aortic aneurysm.

Authors:  Lars Ehlers; Kim Overvad; Jan Sørensen; Søren Christensen; Merete Bech; Mette Kjølby
Journal:  BMJ       Date:  2009-06-24
View more
  17 in total

1.  Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling.

Authors:  Hawre Jalal; Jeremy D Goldhaber-Fiebert; Karen M Kuntz
Journal:  Med Decis Making       Date:  2015-04-03       Impact factor: 2.583

2.  A practical guide to value of information analysis.

Authors:  Edward C F Wilson
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

3.  Health Departments' Engagement in Emergency Preparedness Activities: The Influence of Health Informatics Capacity.

Authors:  Gulzar H Shah; Bobbie Newell; Ruth E Whitworth
Journal:  Int J Health Policy Manag       Date:  2016-10-01

4.  The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis.

Authors:  Eric Jutkowitz; Fernando Alarid-Escudero; Karen M Kuntz; Hawre Jalal
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

Review 5.  HTA agencies facing model biases: the case of type 2 diabetes.

Authors:  Véronique Raimond; Jean-Michel Josselin; Lise Rochaix
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

6.  Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment.

Authors:  David D Kim; Gregory F Guzauskas; Caroline S Bennette; Anirban Basu; David L Veenstra; Scott D Ramsey; Josh J Carlson
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

7.  Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group.

Authors:  Caroline S Bennette; David L Veenstra; Anirban Basu; Laurence H Baker; Scott D Ramsey; Josh J Carlson
Journal:  Med Decis Making       Date:  2016-03-24       Impact factor: 2.583

8.  Cost-Effectiveness of Treatments for the Management of Bone Metastases: A Systematic Literature Review.

Authors:  Lazaros Andronis; Ilias Goranitis; Sue Bayliss; Rui Duarte
Journal:  Pharmacoeconomics       Date:  2018-03       Impact factor: 4.981

9.  Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies.

Authors:  Anna Heath; Natalia Kunst; Christopher Jackson; Mark Strong; Fernando Alarid-Escudero; Jeremy D Goldhaber-Fiebert; Gianluca Baio; Nicolas A Menzies; Hawre Jalal
Journal:  Med Decis Making       Date:  2020-04-16       Impact factor: 2.583

10.  Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US.

Authors:  Pamela P Pei; Milton C Weinstein; X Cynthia Li; Michael D Hughes; A David Paltiel; Taige Hou; Robert A Parker; Melanie R Gaynes; Paul E Sax; Kenneth A Freedberg; Bruce R Schackman; Rochelle P Walensky
Journal:  HIV Clin Trials       Date:  2015-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.